Health Policy - More

Chris Fillip
Executive Vice President, Health Policy
E-mail | 202-729-4123

Back to Health Policy

Health Policy's Home Turf

Washington, DC, is home to Ogilvy PR's Health Policy Group and the senior level counselors who provide health policy communications expertise to the agency's clients. From specialty pharmaceutical companies to medical device manufacturers to industry associations, the Health Policy Group brings inside-the-Beltway insights and communications expertise to our clients. With international reach through Ogilvy PR's global network, we provide solutions to communicating and shaping health policy issues wherever they may arise.

Could Health Policy Get Any More Challenging?

Drug pricing, formulary placement, reimbursement, patent challenges, DTC/DTP promotion practices, ethics, media and Congressional scrutiny of the pharmaceutical and medical device industries and general skepticism are just some of the issues confronting healthcare and healthcare-related companies and their executives. These intersecting issues not only affect bottom line revenues but impact corporate and product brand equity in ways that continue to evolve over time.

Developing effective communications strategies around top policy issues, understanding how the work of product marketing teams and government relations departments can ultimately be complimentary rather than fragmented and siloed is where we excel. We seek to engage our clients' product teams and policy people, understanding that the actions of one affect the outcomes for all.

The Power of Advocacy

Few understand the power of innovation and promise of new drug and device exploration better than the patients and the patient advocacy groups who directly benefit from life-altering and life-changing treatments. We seek to harness the power of advocacy, helping create stronger relationships and enhancing dialogue.

The Health Policy Group At Work

The core competencies of the Health Policy Group are policy communications, issue management and advocacy relations. The following represents some of our work:

  • Developed a communications strategy for a national alliance of patients, patient advocates, physicians and members of the medical device industry to introduce bipartisan legislation to ensure coverage for the screening of a life threatening condition.
  • Created a coalition of manufacturers, physicians and patient advocates to push for inclusion of a demonstration program in the Medicare Modernization Act of 2003.
  • Prepared a medical device manufacturer for media and stakeholder criticisms around product recalls.
  • Supported a patient advocacy summit to discuss the success and the challenges of the Medicare Part D Prescription Drug Benefit.
  • Worked with a leading patient advocacy group to draft federal legislation signed into law in 2004 to incentivize states to protect children from life threatening illnesses in the school setting.
  • Built strategic partnerships with patient and professional advocacy groups to educate about a painful condition that strikes 1 million Americans every year.
  • Created a model plan for the US public affairs group of an international pharmaceutical company to prioritize its health policy issues and identify and prompt an actionable agenda.
  • Garnered significant media coverage around FDA product approvals.

The Health Policy Group offers:

  • Legislative & regulatory affairs
  • Third Party relationship development
  • Coalition building & management
  • Reimbursement communications
  • Issue analysis & management
  • Research and intelligence gathering
  • Grassroots advocacy
  • Congressional testimony preparation
  • Media relations